IRF4 and mature T-cell and NK-cell non-Hodgkin lymphoma: Furthermore, we clarified the previously unrecognized overlap between this entity and PTCL-NOS with extra copies of IRF4 corresponding to increased MYC expression, known in another context as a poor prognostic subtype [35, 57].